Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Australia and New Zealand Banking Group Ltd. Share Issue/Capital Change 2013

Dec 11, 2013

10425_rns_2013-12-11_d31215b6-7a18-48bd-b59e-07a5de8e74d7.pdf

Share Issue/Capital Change

Open in viewer

Opens in your device viewer

Appendix 3B New issue announcement

Ote Rule 2.7, 3.10.3, 3.10.4, 3.10.5

Appendix 3B

New issue announcement, application for quotation of additional securities and agreement

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public.

Introduced 01/07/96 Origin: Appendix 5 Amended 01/07/98, 01/09/99, 01/07/00, 30/09/01, 11/03/02, 01/01/03, 24/10/05, 01/08/12, 04/03/13

Name of entity

Australia and New Zealand Banking Group Limited ( ANZ )

ABN

11 005 357 522

We (the entity) give ASX the following information.

Part 1 - All issues

You must complete the relevant sections (attach sheets if there is not enough space).

1
+Class of+securities issued or to
be issued
2
Number of+securities issued or to
be issued (if known) or maximum
number which may be issued
3
Principal terms of the+securities
(e.g. if options, exercise price and
expiry
date;
if
partly
paid
+securities, the amount outstanding
and due dates for payment; if
+convertible
securities,
the
conversion price and dates for
conversion)
1.
2.
Options to subscribe for ordinary shares.
Fully paid ordinary shares.
1.
2.
2,236,237 options.
8,506 fully paid ordinary shares.
1.2,236,237 options
(A) 39,269 6 Month Deferred Share Rights
(options) exercisable from 1 April 2014 and
before the close of business on 31 March 2016
(after which date the Rights will lapse) at a zero
exercise price; and
(B) 192,539 1 Year Deferred Share Rights
(options) exercisable from 22 November 2014
and before the close of business on 21
November 2016 (after which date the Rights
will lapse) at a zero exercise price; and
(C) 206,019 2 Year Deferred Share Rights
(options) exercisable from 22 November 2015
and before the close of business on 21
November 2017 (after which date the Rights
will lapse) at a zero exercise price; and
(D) 297,941 3 Year Deferred Share Rights
(options) exercisablefrom 22 November 2016
  • See chapter 19 for defined terms.

Appendix 3B Page 1

04/03/2013

Appendix 3B New issue announcement

and before the close of business on 21
November 2018 (after which date the Rights
will lapse) at a zero exercise price; and
(E) 1,447,285 Long Term Incentive (LTI)
Performance Rights (options) exercisable from
22 November 2016 and before the close of
business on 21 November 2018 (after which
date the Rights will lapse) at a zero exercise
price and subject to the following performance
conditions:
The Performance Rights will be granted in
two equal tranches.
Tranche 1 (50% of the grant) will be
subject to a relative TSR performance
condition,
with
a
Selected
Financial
Services comparator group; and
Tranche 2 (50% of the grant) will be
subject to a relative TSR performance
condition, with a S&P/ASX50 comparator
group; and
The proportion of Performance Rights that
become exercisable will depend upon the
TSR achieved by ANZ relative to the
companies in the applicable comparator
group for each tranche. Both tranches will
be measured over the same period (since
date of grant) and calculated as at the end
of the three year performance period.
Performance equal to the median TSR of
the relevant comparator group will result in
half of the Performance Rights for that
tranche
becoming
exercisable.
Each
tranche is measured independently.
Performance above median will result in
further Performance Rights for that tranche
becoming exercisable, increasing on a
straight-line
basis
until
all
of
the
Performance
Rights
for
that
tranche
become exercisable where ANZ’s TSR is
at or above the 75th percentile of TSR in
the relevant comparator group. Where
ANZ’s performance falls between two of
the comparators TSR is measured on a
pro-rata basis. The actual relative level of
TSR, rather than simple ranking, will
determine
the
level
of
vesting.
An
averaging calculation will be used for TSR
over a 90 trading day period for start and
end values in order to reduce share price
volatility.
Each TSR performance hurdle for the two
tranches of Performance Rights will only be
tested once at the end of the three year
performance period. The percentage of
Performance Rights in a tranche that vest as a
result of the TSR calculation will be fixed for the
duration of the exercise period. If the
Performance
Rights
do
not
pass
the
  • See chapter 19 for defined terms.

Appendix 3B Page 2

04/03/2013

Appendix 3B New issue announcement

performance hurdle on the testing date, or they are not exercised by the end of the exercise period (5 years from the date of grant), they will lapse. (F) 25,728 Deferred Share Rights (options) restricted for a period of 3 years and automatically exercised on 4 December 2016 at zero exercise price; and (G) 20,796 Deferred Share Rights (options) exercisable in three tranches, at a zero exercise price. The first tranche (15,530 options) is exercisable from 27 February 2014 and before the close of business on 26 February 2016, the second tranche (3,671 options) from 27 February 2015 and before the close of business on 26 February 2017 and the third tranche (1,595 options) from 27 February 2016 and before the close of business on 26 February 2018. (H) 2,118 Deferred Share Rights (options) exercisable in three tranches, at a zero exercise price. The first tranche (918 options) is exercisable from 20 August 2014 and before the close of business on 19 August 2016, the second tranche (983 options) from 20 August 2015 and before the close of business on 19 August 2017 and the third tranche (217 options) from 20 August 2016 and before the close of business on 19 August 2018. (I) 4,542 Deferred Share Rights (options) exercisable in three tranches, at a zero exercise price. The first tranche (1,438 options) is exercisable from 22 November 2014 and before the close of business on 21 November 2016, the second tranche (1,513 options) from 22 November 2015 and before the close of business on 21 November 2017 and the third tranche (1,591 options) from 22 November 2016 and before the close of business on 21 November 2018. 2. 8,506 fully paid ordinary shares Terms of the shares will be the same as the terms of existing ordinary shares.

  • See chapter 19 for defined terms.

Appendix 3B Page 3

04/03/2013

Appendix 3B New issue announcement

4 Do the[+] securities rank equally in 1. 2,236,237 options all respects from the[+] issue date Inapplicable, as no ANZ options are currently with an existing[+] class of quoted listed save that in the event of exercise the +securities? resulting ordinary shares issued will rank equally in all respects from the date of allotment If the additional[+] securities do not with the existing class of quoted securities. rank equally, please state: • the date from which they do 2. 8,506 fully paid ordinary shares • the extent to which they Yes. participate for the next dividend, (in the case of a trust, distribution) or interest payment • the extent to which they do not rank equally, other than in relation to the next dividend, distribution or interest payment 5 Issue price or consideration 1. 2,236,237 options – zero exercise price 2. Fully paid ordinary shares: 8,506 Shares at $23.71 6 Purpose of the issue 1. 2,236,237 options issued for incentive and/or (If issued as consideration for the retention purpose to new and existing acquisition of assets, clearly employees. identify those assets) 2. 8,506 fully paid ordinary shares issued in connection with the exercise of options. 6a Is the entity an[+] eligible entity that No has obtained security holder approval under rule 7.1A? If Yes, complete sections 6b – 6h in relation to the[+] securities the subject of this Appendix 3B , and comply with section 6i 6b The date the security holder N/A resolution under rule 7.1A was passed 6c Number of +securities issued N/A without security holder approval under rule 7.1 6d Number of[+] securities issued with N/A security holder approval under rule 7.1A

  • See chapter 19 for defined terms.

Appendix 3B Page 4

04/03/2013

Appendix 3B New issue announcement

6e
Number of+securities issued with
security holder approval under rule
7.3, or another specific security
holder approval (specify date of
meeting)
6f
Number of+securities issued under
an exception in rule 7.2
6g
If+securities issued under rule
7.1A, was issue price at least 75%
of 15 day VWAP as calculated
under rule 7.1A.3? Include the
+issue date and both values.
Include the source of the VWAP
calculation.
6h
If+securities were issued under
rule
7.1A
for
non-cash
consideration, state date on which
valuation of consideration was
released
to
ASX
Market
Announcements
6i
Calculate the entity’s remaining
issue capacity under rule 7.1 and
rule 7.1A – complete Annexure 1
and
release
to
ASX
Market
Announcements
7
+Issue dates
Note: The issue date may be prescribed by ASX
(refer to the definition of issue date in rule 19.12).
For example, the issue date for a pro rata
entitlement issue must comply with the applicable
timetable in Appendix 7A.
Cross reference: item 33 of Appendix 3B.
N/A
N/A

N/A
N/A
N/A
1.i) 2,210,509 options - 22 November 2013
ii) 25,728 options – 4 December 2013
2. Fully paid ordinary shares:
1,506 Shares
26/11/2013
7,000 Shares
29/11/2013
  • See chapter 19 for defined terms.

Appendix 3B Page 5

04/03/2013

Appendix 3B New issue announcement

8
Number
and
+class
of
all
+securities
quoted
on
ASX
(including
the
+securities
in
section 2 if applicable)
Number +Class
2,731,487,380
10,812,124
19,687,224
13,400,000
15,086,520
11,200,000
Fully paid ordinary
shares
Fully paid convertible
preference shares
issued in 2008 (CPS1)
Fully paid Convertible
Preference Shares
issued in 2009 (CPS2)
Fully paid Convertible
Preference Shares
issued in 2011 (CPS3)
ANZ Subordinated
Notes
ANZCapital Notes
AUD96,380,000 Floating Rate TCD due
January 2014
AUD1,048,846,000 5.25% TCD due January
2014
AUD1,700,000,000 Floating Rate TCD due
February 2014
AUD600,000,000 6.25% TCD due February
2014
AUD2,500,000,000 Floating Rate TCD due
November 2014
AUD1,375,000,000 6.75% TCD due November
2014
USD1,500,000,000 1.00% Covered Bond due
October 2015
USD750,000,000 Floating Rate Covered Bond
due October 2015
AUD1,000,000,000 Floating Rate TCD due
October 2015
AUD1,450,000,000 Floating Rate TCD due May
2016
AUD775,000,000 6.75%TCDdueMay2016
  • See chapter 19 for defined terms.

Appendix 3B Page 6

04/03/2013

Appendix 3B New issue announcement

Number +Class 9 Number and +class of all 6,062,817 Options on issue +securities not quoted on ASX ( including the +securities in section 2 if applicable) 750,000 2003 Redeemable Preference Shares (Series 2) 500,000 December 2004 Euro Preference Shares

  • 10 Dividend policy (in the case of a 1. Not applicable. trust, distribution policy) on the 2. Same as existing fully paid ordinary shares. increased capital (interests)

Part 2 - Pro rata issue

11
Is
security
holder
approval
required?
12
Is the issue renounceable or non-
renounceable?
13
Ratio in which the+securities will
be offered
14
+Class of+securities to which the
offer relates
15
+Record
date
to
determine
entitlements
16
Will holdings on different registers
(or subregisters) be aggregated for
calculating entitlements?
17
Policy for deciding entitlements in
relation to fractions
18
Names of countries in which the
entity has security holders who will
not be sent new offer documents
Note: Security holders must be told how their
entitlements are to be dealt with.
Cross reference: rule 7.7.
19
Closing
date
for
receipt
of
acceptances or renunciations
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
  • See chapter 19 for defined terms.

Appendix 3B Page 7

04/03/2013

Appendix 3B New issue announcement

20
Names of any underwriters
21
Amount of any underwriting fee or
commission
22
Names of any brokers to the issue
23
Fee or commission payable to the
broker to the issue
24
Amount
of any handling fee
payable to brokers who lodge
acceptances or renunciations on
behalf of security holders
25
If the issue is contingent on security
holders’ approval, the date of the
meeting
26
Date entitlement and acceptance
form and offer documents will be
sent to persons entitled
27
If the entity has issued options, and
the terms entitle option holders to
participate on exercise, the date on
which notices will be sent to option
holders
28
Date rights trading will begin (if
applicable)
29
Date rights trading will end (if
applicable)
30
How do security holders sell their
entitlements_in full_through a
broker?
31
How do security holders sell_part_of
their entitlements through a broker
and accept for the balance?
32
How do security holders dispose of
their entitlements (except by sale
through a broker)?
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
  • See chapter 19 for defined terms.

Appendix 3B Page 8

04/03/2013

Appendix 3B New issue announcement

33 +Issue date

N/A

Part 3 - Quotation of securities

You need only complete this section if you are applying for quotation of securities

  • 34 Type of[+] securities ( tick one )

  • (a) +Securities described in Part 1 (NB: this relates only to the fully paid ordinary shares described in Part 1)

  • (b)[All other ][+][securities ]

Example: restricted securities at the end of the escrowed period, partly paid securities that become fully paid, employee incentive share securities when restriction ends, securities issued on expiry or conversion of convertible securities

Entities that have ticked box 34(a)

Additional securities forming a new class of securities

Tick to indicate you are providing the information or documents

  • 35 If the[+] securities are[+] equity securities, the names of the 20 largest holders of the additional[+] securities, and the number and percentage of additional[+] securities held by those holders

  • 36 If the[+] securities are[+] equity securities, a distribution schedule of the additional +securities setting out the number of holders in the categories 1 - 1,000 1,001 - 5,000 5,001 - 10,000 10,001 - 100,000 100,001 and over

  • 37 A copy of any trust deed for the additional[+] securities

  • See chapter 19 for defined terms.

Appendix 3B Page 9

04/03/2013

Appendix 3B New issue announcement

Entities that have ticked box 34(b)

38
Number of+securities for which
+quotation is sought
39
+Class of
+securities for which
quotation is sought
40
Do the+securities rank equally in all
respects from the+issue date with an
existing+class of quoted+securities?
If the additional+securities do not
rank equally, please state:
• the date from which they do
• the
extent
to
which
they
participate for the next dividend,
(in
the
case
of
a
trust,
distribution) or interest payment
• the extent to which they do not
rank equally, other than in
relation to the next dividend,
distribution or interest payment
41
Reason for request for quotation
now
Example: In the case of restricted securities, end of
restriction period
(if issued upon conversion of
another+security, clearly identify
that other+security)
42
Number and+class of all+securities
quoted on ASX (_including_the
+securities in clause 38)
N/A
N/A
N/A
N/A
Number +Class
N/A N/A
  • See chapter 19 for defined terms.

Appendix 3B Page 10

04/03/2013

Appendix 3B New issue announcement

Quotation agreement

  • 1 +Quotation of our additional +securities is in ASX’s absolute discretion. ASX may quote the[+] securities on any conditions it decides.

  • 2 We warrant the following to ASX.

  • The issue of the[+] securities to be quoted complies with the law and is not for an illegal purpose.

  • There is no reason why those[+] securities should not be granted[+] quotation.

  • An offer of the[+] securities for sale within 12 months after their issue will not require disclosure under section 707(3) or section 1012C(6) of the Corporations Act.

Note: An entity may need to obtain appropriate warranties from subscribers for the securities in order to be able to give this warranty

  • Section 724 or section 1016E of the Corporations Act does not apply to any applications received by us in relation to any[+] securities to be quoted and that no-one has any right to return any[+] securities to be quoted under sections 737, 738 or 1016F of the Corporations Act at the time that we request that the[+] securities be quoted.

  • If we are a trust, we warrant that no person has the right to return the +securities to be quoted under section 1019B of the Corporations Act at the time that we request that the[+] securities be quoted.

  • 3 We will indemnify ASX to the fullest extent permitted by law in respect of any claim, action or expense arising from or connected with any breach of the warranties in this agreement.

  • 4 We give ASX the information and documents required by this form. If any information or document is not available now, we will give it to ASX before +quotation of the +securities begins. We acknowledge that ASX is relying on the information and documents. We warrant that they are (will be) true and complete.

Sign here:

............................................................ Date: 12 December 2013

Company Secretary

Print name: John Priestley

== == == == ==

  • See chapter 19 for defined terms.

Appendix 3B Page 11

04/03/2013

Appendix 3B New issue announcement

Appendix 3B – Annexure 1

Calculation of placement capacity under rule 7.1 and rule 7.1A for eligible entities

Introduced 01/08/12 Amended 04/03/13

Part 1

Rule 7.1 – Issues exceeding 15% of capital

Step 1: Calculate “A”, the base figure from which the placement capacity is calculated

Insert number of fully paid[+] ordinary securities on issue 12 months before the + issue date or date of agreement to issue

Add the following:

  • Number of fully paid[+] ordinary securities issued in that 12 month period under an exception in rule 7.2

  • Number of fully paid[+] ordinary securities issued in that 12 month period with shareholder approval

  • Number of partly paid[+] ordinary securities that became fully paid in that 12 month period

Note:

  • Include only ordinary securities here – other classes of equity securities cannot be added

  • • Include here (if applicable) the securities the subject of the Appendix 3B to which this form is annexed

  • • It may be useful to set out issues of securities on different dates as separate line items

  • Subtract the number of fully paid[+] ordinary securities cancelled during that 12 month period “A”

  • See chapter 19 for defined terms.

Appendix 3B Page 12

04/03/2013

Appendix 3B New issue announcement

Step 2: Calculate 15% of “A”
“B” 0.15
[Note: this value cannot be changed]
Multiply“A” by 0.15
Step 3: Calculate “C”, the amount of placement capacity under rule
7.1 that has already been used
Insertnumber of+equity securities issued
or agreed to be issued in that 12 month
period_not counting_those issued:
• Under an exception in rule 7.2
• Under rule 7.1A
• With security holder approval under rule
7.1 or rule 7.4
Note:
• This applies to equity securities, unless
specifically excluded – not just ordinary
securities
• Include here (if applicable) the
securities the subject of the Appendix
3B to which this form is annexed
• It may be useful to set out issues of
securities on different dates as separate
line items
“C”
Step 4: Subtract “C” from [“A” x “B”] to calculate remaining
placement capacity under rule 7.1
“A” x 0.15
Note: number must be same as shown in
Step 2
Subtract“C”
Note: number must be same as shown in
Step 3
Total[“A” x 0.15] – “C” [Note: this is the remaining placement
capacity under rule 7.1]
  • See chapter 19 for defined terms.

Appendix 3B Page 13

04/03/2013

Appendix 3B New issue announcement

Part 2

Rule 7.1A – Additional placement capacity for eligible entities

Step 1: Calculate “A”, the base figure from which the placement capacity is calculated

“A” Note: number must be same as shown in Step 1 of Part 1

Step 2: Calculate 10% of “A”

“D”

0.10

Note: this value cannot be changed Multiply “A” by 0.10

Step 3: Calculate “E”, the amount of placement capacity under rule 7.1A that has already been used

Insert number of[+] equity securities issued or agreed to be issued in that 12 month period under rule 7.1A

Notes:

  • This applies to equity securities – not just ordinary securities

  • Include here – if applicable – the securities the subject of the Appendix 3B to which this form is annexed

  • Do not include equity securities issued under rule 7.1 (they must be dealt with in Part 1), or for which specific security holder approval has been obtained

  • It may be useful to set out issues of securities on different dates as separate line items

  • “E”

  • See chapter 19 for defined terms.

Appendix 3B Page 14

04/03/2013

Appendix 3B New issue announcement

Step 4: Subtract “E” from [“A” x “D”] to calculate remaining placement capacity under rule 7.1A

“A” x 0.10 Note: number must be same as shown in Step 2 Subtract “E” Note: number must be same as shown in Step 3 Total [“A” x 0.10] – “E” Note: this is the remaining placement capacity under rule 7.1A

  • See chapter 19 for defined terms.

Appendix 3B Page 15

04/03/2013